Table 4. Correlations Among UACR and Blood Pressure, HbA1c, and Body Weight.
| Interventional trial period (week 24) |
Post-trial monitoring period (week 104) |
|||||||
|---|---|---|---|---|---|---|---|---|
| All patients (n = 50) |
Diabetic nephropathy (n = 16) |
All patients (n = 50) |
Diabetic nephropathy (n = 16) |
|||||
| ΔUACR (mg/gCr) |
ΔUACR (mg/gCr) |
ΔUACR (mg/gCr) |
ΔUACR (mg/gCr) |
|||||
| r | P | r | P | r | P | r | P | |
| ΔSBP (mm Hg) | 0.342 | 0.015 | 0.504 | 0.047 | 0.074 | 0.619 | 0.140 | 0.606 |
| ΔDBP (mm Hg) | 0.110 | 0.445 | 0.148 | 0.585 | 0.057 | 0.698 | 0.044 | 0.870 |
| ΔHbA1c (%) | 0.041 | 0.780 | 0.048 | 0.860 | -0.058 | 0.697 | -0.135 | 0.617 |
| ΔBW (kg) | 0.218 | 0.128 | 0.476 | 0.062 | -0.071 | 0.631 | -0.017 | 0.949 |
The relationship between changes in UACR and blood pressure, HbA1c, and body weight were assessed using Pearson’s correlation coefficients. Δ: the amount of change week 24 or week 104 after baseline. UACR: urinary albumin-to-creatinine ratio; HbA1c: glycated hemoglobin; SBP: systolic blood pressure; DBP: diastolic blood pressure; BW: body weight.